The Venture Codex Logo

The Venture Codex

Overview

Bioseparation products for removing target cells from biological samples.

Total Raised

$39 M

Rounds

3

Links

Verticals

Biotechnology
Information Technology
Life Science
Medical

Investment History

  1. Equity

    Jun 2025

    $20M

  2. Series B

    Oct 2021

    $18M

  3. Seed

    Oct 2015

    $1M

Team

Brandon McNaughton

Co-Founder & CEO

Brock Siegel

Director and Contract-COO

Ken Gordon

Business Management

Stephanie Camacho

Director of Marketing and Product Management